Actually it was the Phase II Trials that were funded:
Immuron was awarded AU $4.8 (USD $3.43) million funding to perform a randomized double-blind placebo-controlled phase 2 trials
"Immuron is in the process of exploring non-dilutive funding opportunities for these Phase 3 clinical trials."
final Phase II clinical study report will be completed in H2 2024.
The Interesting bit to me was they were already selling their products,
Before Phase III Trials have been completed....
BIT036- a likely candidate for curing COVID-19, page-1784
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
